SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-336245"
 

Search: onr:"swepub:oai:DiVA.org:uu-336245" > Associations betwee...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Schwartzbaum, Judith (author)

Associations between prediagnostic blood glucose levels, diabetes, and glioma.

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • 2017-05-03
  • Springer Science and Business Media LLC,2017
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-336245
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-336245URI
  • https://doi.org/10.1038/s41598-017-01553-2DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136189URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:135784161URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Previous literature indicates that pre-diagnostic diabetes and blood glucose levels are inversely related to glioma risk. To replicate these findings and determine whether they could be attributed to excess glucose consumption by the preclinical tumour, we used data from the Apolipoprotein MOrtality RISk (AMORIS) (n = 528,580) and the Metabolic syndrome and Cancer project (Me-Can) cohorts (n = 269,365). We identified individuals who were followed for a maximum of 15 years after their first blood glucose test until glioma diagnosis, death, emigration or the end of follow-up. Hazard ratios (HRs), 95% confidence intervals (CIs) and their interactions with time were estimated using Cox time-dependent regression. As expected, pre-diagnostic blood glucose levels were inversely related to glioma risk (AMORIS, P trend = 0.002; Me-Can, P trend = 0.04) and pre-diagnostic diabetes (AMORIS, HR = 0.30, 95% CI 0.17 to 0.53). During the year before diagnosis, blood glucose was inversely associated with glioma in the AMORIS (HR = 0.78, 95% CI 0.66 to 0.93) but not the Me-Can cohort (HR = 0.99, 95% CI 0.63 to 1.56). This AMORIS result is consistent with our hypothesis that excess glucose consumption by the preclinical tumour accounts for the inverse association between blood glucose and glioma. We discuss additional hypothetical mechanisms that may explain our paradoxical findings.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Edlinger, Michael (author)
  • Zigmont, Victoria (author)
  • Stattin, PärUmeå universitet,Uppsala universitet,Urologkirurgi,Urologi och andrologi(Swepub:umu)past0003 (author)
  • Rempala, Grzegorz A (author)
  • Nagel, Gabriele (author)
  • Hammar, NiklasKarolinska Institutet (author)
  • Ulmer, Hanno (author)
  • Föger, Bernhard (author)
  • Walldius, GöranKarolinska Institutet (author)
  • Manjer, Jonas (author)
  • Malmström, HåkanKarolinska Institutet (author)
  • Feychting, MariaKarolinska Institutet (author)
  • Uppsala universitetUrologkirurgi (creator_code:org_t)

Related titles

  • In:Scientific Reports: Springer Science and Business Media LLC7:12045-2322

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view